Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
NCT ID: NCT01602419
Last Updated: 2021-01-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2012-10-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD
NCT04052698
Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor
NCT04555785
A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
NCT06205095
Molecular and Clinical Profile of Von Willebrand Disease in Spain
NCT02869074
An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
NCT06883240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients using Wilate as standard of care treatment
This patient population is being treated with Wilate as standard of care treatment
Patients using Wilate as standard of care
Patients with von Willebrand Disease using Wilate for a period of 2 years.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients using Wilate as standard of care
Patients with von Willebrand Disease using Wilate for a period of 2 years.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Octapharma
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Los Angeles Biomedical Research Institute
Torrance, California, United States
Nicklaus Children's Hospital
Miami, Florida, United States
University of Utah
Salt Lake City, Utah, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Fundación de la Hemofilia de Salta
Salta, , Argentina
University of Alberta
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
St. John Regional Hospital
Saint John, New Brunswick, Canada
Eastern Regional Health Authority
St. John's, Newfoundland and Labrador, Canada
McMaster University
Hamilton, Ontario, Canada
Queens University
Kingston, Ontario, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
University Hospital Ostrava
Ostrava-Poruba, , Czechia
Werlhof-Institut
Hanover, , Germany
Centro Hospitalar Cova da Beira
Covilha, , Portugal
Hospital Universitario de Burgos
Burgos, , Spain
Hospital San Pedro de Alcantara
Cáceres, , Spain
Hospital Fundacion Jiminez Diaz
Madrid, , Spain
Skåne University Hospital
Malmo, , Sweden
Great Ormond Street Hospital for Children
London, , United Kingdom
Hospital Pereira Rossell
Montevideo, , Uruguay
Sanatorio Americano
Montevideo, , Uruguay
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wil-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.